Table 5.
2-yr survival and rebleeding rate in randomized controlled trials comparing DSRS with ES
| Warren[5] | Terés[7] | Rikkers[6] | Our data | |
| 2-yr survival rate | ||||
| after DSRS | 59%a | 71% | 65% | 95% |
| 2-yr survival rate | ||||
| after ES | 84%a | 68% | 61% | 85% |
| Child's C patients | 43% | 0 | 33% | 0 |
| Interval between bleeding | ||||
| and treatment (d) | > 3-5 | 10-15 | NR | 901 |
| Rebleeding rate after | ||||
| DSRS | 3%a | 14%a | 19%a | 2.5%a |
| Rebleeding rate after | ||||
| ES | 53%a | 37%a | 57%a | 35%a |
| Variceal eradication | ||||
| rate | NR | 46% | 63% | 90% |
| Failure to salvage | ||||
| rebleeders | 17% | 33% | 47% | 14% |
| Shunt for ES failure | 31% | 6% | 7% | 5% |
| Global mortality rate | ||||
| due to rebleeding | 3% | 14% | 27% | 16% |
| Global mortality rate | ||||
| due to other causes | 13% | 16% | 13% | 17% |
NR = Not reported; 1mean value;
P < 0.05 vs ES.